LOPINAVIR
- UNII: 2494G1JF75
- Formula: C37H48N4O5
- Preferred Substance Name: LOPINAVIR
- InChIKey: KJHKTHWMRKYKJE-SUGCFTRWSA-N
- 192725-17-0
- (.ALPHA.S)-TETRAHYDRO-N-((.ALPHA.S)-.ALPHA.-((2S,3S)-2-HYDROXY-4-PHENYL-3-(2-(2,6-XYLYLOXY)ACETAMIDO)BUTYL)PHENETHYL)-.ALPHA.-ISOPROPYL-2-OXO-1(2H)-PYRIMIDINEACETAMIDE
- (1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2-OXO-1(2H)-PYRIMIDINEACETAMIDE
- (S)-N-((2S,4S,5S)-5-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-4-HYDROXY-1,6-DIPHENYLHEXAN-2-YL)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDE
- A-157378.0
- A-157378-0
- ABT-378
- ALUVIRAN
- KALETRA COMPONENT LOPINAVIR
- KOLETRA
- LOPINAVIR [EMA EPAR]
- LOPINAVIR [EP MONOGRAPH]
- LOPINAVIR [INN]
- LOPINAVIR [JAN]
- LOPINAVIR [MART.]
- LOPINAVIR [MI]
- LOPINAVIR [ORANGE BOOK]
- LOPINAVIR [USAN]
- LOPINAVIR [USP MONOGRAPH]
- LOPINAVIR [USP-RS]
- LOPINAVIR [VANDF]
- LOPINAVIR [WHO-DD]
- LOPINAVIR [WHO-IP]
- LOPINAVIR, (S-(2S,4S,5S))-
- LOPINAVIRUM [WHO-IP LATIN]
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
